Illumina Inks Co-Marketing Pacts with Caliper, Sage Science for Next-Gen Sequencing Sample Prep | GenomeWeb

Illumina said today that it has inked separate co-marketing agreements with Caliper Life Sciences and Sage Science to promote use of those companies' sample prep systems in next-generation sequencing applications.

Under the first agreement, Illumina will promote Caliper's LabChip XT, a preparative microfluidic platform for separating DNA fragments of different sizes that uses multi-channel disposable chips to run up to four samples in less than 30 minutes. Caliper said that the platform was developed "with direct input" from Illumina.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.